Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-21 to 2024-07-15
Current total value of award: $4006.04
Description: 4565004069!OZURDEX 0.7 MG IMPLANTS